These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17084674)

  • 1. Menopause: evidence-based practice.
    Blake J
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):799-839. PubMed ID: 17084674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
    Henderson VW
    Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive aging, menopause, and health outcomes.
    Pinkerton JV; Stovall DW
    Ann N Y Acad Sci; 2010 Aug; 1204():169-78. PubMed ID: 20738288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dydrogesterone in hormone replacement therapy.
    Mueck AO; Seeger H; Bühling KJ
    Maturitas; 2009 Dec; 65 Suppl 1():S51-60. PubMed ID: 19836909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are progestins really necessary as part of a combined HRT regimen?
    Sturdee DW
    Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopause: providing comprehensive care for women in transition.
    McAllister M
    Lippincotts Prim Care Pract; 1998; 2(3):256-70. PubMed ID: 9644441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of menopausal vasomotor symptoms.
    Med Lett Drugs Ther; 2004 Dec 6-20; 47(1197-1198):98-9. PubMed ID: 15583526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.